N-Zyme Biomedical
PrivateLast Round
Series A
Jul 22, 2026
Total Funding Raised
$4.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
N-Zyme Biomedical operates in Healthcare & Life Sciences and is based in Newark, Delaware. Its latest recorded funding round was a Series A round in July 2026.
N-Zyme Biomedical is a clinical-stage biotechnology company developing first-in-class therapies targeting pepsin to treat laryngopharyngeal reflux and gastroesophageal reflux disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
N-Zyme Biomedical Comparables
Compare N-Zyme Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ellodi Pharmaceuticals | 68% | |
| The Reflux Company | 66% | |
| Phathom Pharmaceuticals | 66% |
For institutional investors. Book with your work email.
N-Zyme Biomedical Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 76% MoM, reaching 4.8K.
- Jul 22, 2026
$5M round completed.
For institutional investors. Book with your work email.
N-Zyme Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about N-Zyme Biomedical's valuation, stock price, and market status.
Is N-Zyme Biomedical a public or private company?
N-Zyme Biomedical is a private company.
What is the current stock price of N-Zyme Biomedical?
N-Zyme Biomedical is a private company, so its shares have no public market price. Caplight tracks N-Zyme Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is N-Zyme Biomedical worth (valuation)?
Valuation information for N-Zyme Biomedical is not publicly available.
Can I buy N-Zyme Biomedical stock?
N-Zyme Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was N-Zyme Biomedical's last funding round?
N-Zyme Biomedical's most recent funding round was Series A on July 22, 2026.
Who are the main investors in N-Zyme Biomedical?
Investor information for N-Zyme Biomedical is not publicly disclosed.
Will N-Zyme Biomedical IPO soon?
No public IPO plans have been announced for N-Zyme Biomedical.
How can I track N-Zyme Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in N-Zyme Biomedical's shares on secondary markets.